10.1021/acsnano.9b05579 ACS Nano 352 VivsE.BrodinP.LebleuB
43 These results highlight the therapeutic potential of semaglutide in addressing the metabolic and functional impairments common in this HFpEF phenotype
Peer review Peer review information Nature Medicine thanks Harald Mischak and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Why direct conversion is problematic Semaglutide and tirzepatide have different receptor binding profiles, different potencies at the GLP-1 receptor, and tirzepatide has an additional receptor target entirely
However, in individuals with a confirmed or subclinical B12 deficiency, correcting that deficiency can lead to the following: Improved energy levels and reduced fatigue Better exercise tolerance and recovery More stable mood and motivation Improved sleep quality These are indirect but meaningful contributors to weight management
Should I take a break from Retatrutide if it stops working